X
19
Fougera Pharmaceuticals Inc., based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is BETAMETHASONE DIPROPIONATE, with a corresponding application number 75373.
Regulatory Information RX
With a dosage strength EQ 0.05% BASE
Dosage Form Route OINTMENT, AUGMENTED; TOPICAL
Reference Listed Drug No
Approved since 1999-06-22
Therapeutic Equivalence (TE) Code AB